Advances in the treatment of hypertriglyceridemic pancreatitis
DOI:10.3969/j.issn.1001-5256.2020.12.047
- VernacularTitle:高三酰甘油血症性急性胰腺炎治疗进展
- Author:
Chengsi ZHAO
1
;
Weijie YAO
;
Zuozheng WANG
Author Information
1. Department of Hepatobiliary Surgery, General Hospital of Ningxia Medical University, Yinchuan 750004, China
- Publication Type:Research Article
- Keywords:
pancreatitis;
hyperlipidemias;
therapeutics
- From:
Journal of Clinical Hepatology
2020;36(12):2860-2864
- CountryChina
- Language:Chinese
-
Abstract:
The incidence rate of hypertriglyceridemic pancreatitis (HTGP) is gradually increasing, and its complex pathogenesis has not been fully elucidated, which causes the difficulty in treatment. At present, there are no recommended guidelines for the treatment of HTGP. According to the process of the development and progression of HTGP, this article reviews related articles in China and foreign countries from the aspects of treatment during acute exacerbation, treatment for the special population, and long-term prevention of recurrence.
